Reasons for thanks, with a long road ahead
By Kyle Tetting
November has given us much to be thankful for. Though the exponential growth of positive coronavirus cases continues to weigh, news from Pfizer, Moderna and AstraZeneca may finally be showing us the light at the end of the tunnel. While stocks had shown strength on the hope of this news, November brought more concrete signs that economic growth may follow a successful vaccine.